MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 72 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,587 | -63.9% | 27,590 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $9,932 | -23.4% | 27,590 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $12,967 | -13.8% | 27,590 | -8.3% | 0.00% | 0.0% |
Q4 2022 | $15,045 | -20.8% | 30,090 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $19,000 | -20.8% | 30,090 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $24,000 | 0.0% | 30,090 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $24,000 | -7.7% | 30,090 | +16.1% | 0.00% | 0.0% |
Q4 2021 | $26,000 | -13.3% | 25,925 | +12.1% | 0.00% | 0.0% |
Q3 2021 | $30,000 | +87.5% | 23,125 | +12.1% | 0.00% | +100.0% |
Q2 2021 | $16,000 | -27.3% | 20,625 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $22,000 | -21.4% | 20,625 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $28,000 | +75.0% | 20,625 | 0.0% | 0.00% | +50.0% |
Q3 2020 | $16,000 | 0.0% | 20,625 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $16,000 | +33.3% | 20,625 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $12,000 | -74.5% | 20,625 | 0.0% | 0.00% | -66.7% |
Q4 2019 | $47,000 | +261.5% | 20,625 | 0.0% | 0.01% | +200.0% |
Q3 2019 | $13,000 | – | 20,625 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 1,429,532 | $1,944,000 | 0.61% |
Boxer Capital, LLC | 11,478,634 | $15,611,000 | 0.50% |
Vivo Capital, LLC | 6,451,612 | $8,774,000 | 0.39% |
Philadelphia Financial Management of San Francisco, LLC | 740,861 | $1,008,000 | 0.26% |
DCF Advisers, LLC | 305,299 | $415,000 | 0.17% |
Main Street Financial Solutions, LLC | 400,826 | $545,000 | 0.11% |
Platform Technology Partners | 158,660 | $216,000 | 0.10% |
STALEY CAPITAL ADVISERS INC | 600,000 | $816,000 | 0.05% |
MONECO Advisors, LLC | 50,000 | $81,000 | 0.04% |
CCG WEALTH MANAGEMENT, LLC | 30,000 | $41,000 | 0.04% |